Skip to main content
SpringerLink
Log in

Pfizer discontinued their phase III trial of sunitinib [Sutent] in advanced liver cancer,

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Pfizer Inc.Pfizer Discontinues Phase 3 Trial of Sutent (Rm) in Advanced Hepatocellular Carcinoma. Media Release: 23 Apr 2010. Available from: URL: http://www.pfizer.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfizer discontinued their phase III trial of sunitinib [Sutent] in advanced liver cancer,. React. Wkly. 1300, 4 (2010). https://doi.org/10.2165/00128415-201013000-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013000-00008

Keywords

Search

Navigation